LMB763 (nidufexor) (Novartis (GNF) oral in vivo selective FXR partial agonist)
< 1 minute read
Sep. 15, 2021
LMB763: A selective FXR partial agonist
LMB763 (nidufexor)
selective FXR partial agonist orally efficacious in NASH models from two 3M compound HTS and LBD J. Med. Chem., Jan. 15, 2020 Novartis (GNF), San Diego, CA